Markets:

Overview

News

Currencies

International

Treasuries

Summit Therapeutics Inc. - Common Stock (NQ:SMMT)

14.01 -0.17 (-1.20%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jun 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Summit Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

18 19 Next >

Marvell Technology, eBay, And DexCom Are Among Top 10 Large Cap Losers Last Week (August 25-August 29): Are The Others In Your Portfolio? ↗

August 31, 2025

Marvell, Hormel, and Keurig Dr Pepper led weekly large-cap losers on weak guidance and analyst downgrades.

Via Benzinga

3 No-Brainer Stocks to Buy Right Now ↗

August 31, 2025

Investing in these pharmaceutical stocks is an easy decision.

Via The Motley Fool

Topics World Trade

Summit, Akeso Report Lung Cancer Survival Boost With Ivonescimab, A Rival To Merck's Keytruda Multi-Billion Dollar Franchise, Says Analyst ↗

August 27, 2025

Summit and Akeso report ivonescimab's survival benefit in lung cancer, boosting approval odds and positioning it as a Keytruda challenger.

Via Benzinga

JM Smucker, Baidu And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

August 27, 2025

Via Benzinga

Navigating the Currents: Top Sectors Primed for Growth in Q3 2025

August 27, 2025

The global economy is sailing into Q3 2025 with a blend of cautious optimism and persistent challenges. While a new tariff regime and elevated geopolitical tensions introduce elements of uncertainty,...

Via MarketMinute

Topics Artificial Intelligence Economy Retirement

Summit Draws Frenzied Retail Chatter After Akeso Drug Shows Survival Benefit In Lung Cancer; Retail Sees More Upside ↗

August 26, 2025

Analysts at Bernstein called the survival data “a positive surprise,” framing it as Akeso’s biggest catalyst since the drug previously outperformed Merck’s top-selling cancer therapy.

Via Stocktwits

BeOne Cashes In On Amgen's Cancer Drug Royalties In Multibillion-Dollar Pharma Tie-Up ↗

August 25, 2025

BeOne Medicines will sell global Imdelltra royalties to Royalty Pharma for up to $950 million while retaining rights to other oncology programs with Amgen.

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 21, 2025

Via Benzinga

3 Fantastic Growth Stocks to Buy in August ↗

August 17, 2025

Only one of these growth stocks is up big so far in 2025. But all three could be huge winners over the next few years.

Via The Motley Fool

Ivonescimab Data from Global Phase III HARMONi Study to be Showcased at Presidential Symposium at WCLC 2025

August 14, 2025

From Summit Therapeutics

Via Business Wire

Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter Ended June 30, 2025

August 11, 2025

From Summit Therapeutics

Via Business Wire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT

July 23, 2025

From Pomerantz LLP

Via GlobeNewswire

3 Healthcare Stocks to Buy Before They Announce Game-Changing Clinical Trial Results ↗

July 22, 2025

Via The Motley Fool

This Healthcare Stock's Revolutionary Drug Could Make Early Investors Rich ↗

July 21, 2025

Via The Motley Fool

3 Monster Stocks in the Making to Buy Right Now ↗

July 21, 2025

Via The Motley Fool

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT

July 18, 2025

From Pomerantz LLP

Via GlobeNewswire

10 Health Care Stocks Whale Activity In Today's Session ↗

July 16, 2025

Via Benzinga

Johnson & Johnson Raises FY25 Forecast, Joins Rigetti Computing, Unity Software, Brighthouse Financial And Other Big Stocks Moving Higher On Wednesday ↗

July 16, 2025

Via Benzinga

SMMT Investors Have Opportunity to Join Summit Therapeutics Inc. Fraud Investigation with the Schall Law Firm

July 14, 2025

From The Schall Law Firm

Via Business Wire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Summit Therapeutics Inc. - SMMT

July 14, 2025

From Pomerantz LLP

Via GlobeNewswire

Why Is AbbVie Stock Trading Higher On Thursday? ↗

July 10, 2025

AbbVie licensed IGI's trispecific myeloma drug ISB 2001 in a deal worth up to $1.925 billion following strong early-phase clinical data.

Via Benzinga

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT

July 10, 2025

From Pomerantz LLP

Via GlobeNewswire

Merck Strikes $10-Billion Deal For Verona, Secures First-In-Class COPD Drug ↗

July 09, 2025

Merck is acquiring Verona Pharma for $10 billion, gaining COPD drug Ohtuvayre as part of its strategy to offset Keytruda's looming patent loss.

Via Benzinga

Topics Intellectual Property

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT

July 06, 2025

From Pomerantz LLP

Via GlobeNewswire

NIKE, Datadog And Snap Are Among Top 11 Large Cap Gainers Last Week (June 30-July 4): Are The Others In Your Portfolio? ↗

July 06, 2025

11 best performing large-cap stocks last week, including Symbotic, Nike, First Solar, Datadog, HPE, Summit Therapeutics, Carnival, POSCO, Wynn Resorts, SharkNinja, and Snap

Via Benzinga

2 Soaring Stocks With More Upside Potential to Buy and Hold ↗

July 04, 2025

Via The Motley Fool

Why AstraZeneca Stock Got Thumped on Thursday ↗

July 03, 2025

Via The Motley Fool

Why Summit Therapeutics Stock Soared 8% Higher Today ↗

July 03, 2025

Via The Motley Fool

AstraZeneca In $15B Talks For Drug That Could Upend Lung Cancer Treatment ↗

July 03, 2025

Via Benzinga

AstraZeneca In Talks To License Summit Therapeutics’ Experimental Lung Cancer Drug: Report ↗

July 03, 2025

While the terms of the partnership agreement are still being negotiated, it could include an upfront payment worth several billion dollars and milestone payments, Bloomberg reported, while noting that...

Via Stocktwits

< Previous 1 2 3 4 5 6 7 8 9

...

18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.